Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Next and Synthomer cut outlook; new M&G CEO

Thu, 29th Sep 2022 07:49

(Alliance News) - The mood soured just before the European equities open on Thursday.

The Swedish Coast Guard found another leak in undersea gas pipelines running from Russia to Europe.

Stocks had initially been called higher on Thursday, with the Bank of England's bond market intervention lifting the mood.

The Nord Stream news put paid to hopes for a positive open in Europe, however.

"There are two leaks on the Swedish side and two leaks on the Danish side," a Swedish Coast Guard official said, after three leaks were confirmed earlier this week on the Nord Stream pipelines in the Baltic Sea.

Meanwhile, UK retailer Next lowered its guidance for annual sales and profit.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called down 0.3% at 6,982.29

----------

Hang Seng: down 0.8% at 17,105.61

Nikkei 225: closed up 1.0% at 26,422.05

S&P/ASX 200: closed up 1.4%. at 6,555.00

----------

DJIA: closed up 548.75 points, or 1.9%, at 29,683.74

S&P 500: closed up 71.75 points, or 2.0%, at 3,719.04

Nasdaq Composite: closed up 222.13 points, or 2.1%, at 11,051.64

----------

EUR: up at USD0.9660 (USD0.9645)

GBP: firm at USD1.0772 (USD1.0763)

USD: up at JPY144.68 (JPY144.41)

GOLD: lower at USD1,644.93 per ounce (USD1,653.20)

OIL (Brent): flat at USD88.23 a barrel (USD88.17)

(changes since previous London equities close)

----------

ECONOMICS

----------

Thursday's key economic events still to come:

1000 BST eurozone economic sentiment indicator

1300 BST Germany consumer price index

1330 BST US gross domestic product

1330 BST US initial jobless claims

----------

Kemi Badenoch has used her first overseas visit as UK trade secretary to defend the government's economic strategies as "going for growth in a big way". There has been controversy since Chancellor Kwasi Kwarteng last week announced his mini-budget, which included plans to cut taxes to the benefit of the most wealthy. Badenoch told investors at the fifth annual Atlantic Future Forum hosted on the HMS Queen Elizabeth, moored in New York, the strategies were necessary due to a "global growth slow-down". The former Tory leadership candidate outlined a number of the government's strategies to the forum, where UK businesses across the defence and technology sector aimed to attract US investors.

----------

The number of cars built in the UK has increased for the fourth month in a row, new figures show. A total of 49,901 cars were built in August, up 34% compared with a year ago, the Society of Motor Manufacturers & Traders said. But the figure was well below August 2019's pre-pandemic level of 92,158 units, which the SMMT said underlined the scale of recovery still needed in the industry. Production of battery electric, plug-in hybrid and hybrid vehicles increased. Almost a third of all cars made in Britain in August were one of these models, with most exported to global markets.

----------

Price sensitivity is showing signs of returning to the UK housing market as house hunters' buying power takes a hit, according to a property website. Zoopla said 6% of homes listed for sale have seen the asking price adjusted downwards by 5% or more, marking the highest level since before the coronavirus pandemic. The website said that, given the economic backdrop and factors including rising energy prices and rising interest rates, this is a clear sign of a return to more of a buyers' market, after two years of a market that favoured sellers. The findings were released in a week when a slew of mortgage products have been pulled from the market and rates have been hiked, amid turmoil after the mini-budget last Friday.

----------

BROKER RATING CHANGES

----------

Oddo BHF raises GSK to 'outperform' ('neutral') - price target 1,700 (1,540) pence

----------

RBC cuts THG to 'sector perform' ('outperform') - price target 50 (215) pence

----------

RBC cuts boohoo price target to 35 (65) pence - 'sector perform'

----------

Goldman Sachs cuts boohoo price target to 65 (115) pence - 'buy'

----------

COMPANIES - FTSE 100

----------

Next lowered annual guidance as the clothing and homewares retailer believes tough trading in August and cost-of-living pressures will offset any boost from recent UK government stimulus measures. In the half-year ended July 30, revenue climbed 12% to GBP2.38 billion from GBP2.12 billion a year earlier. Pretax profit advanced 16% year-on-year to GBP400.6 million from GBP346.7 million. Full price sales advanced 12% year-on-year in the first half, though the company now expects a decline for the second half. Full price sales are to shrink by 1.5% year-on-year. It had previously guided for 1% growth. Next also lowered bottom-line guidance. It now expects annual pretax profit of GBP840 million, down from the previous GBP860 million guidance, but up 2.1% on last year. "August trade was below our expectations and cost of living pressures are set to rise in the coming months. Sales in September have improved, and we may see benefits from recent government measures," Next said, adding that the decision to lower full price sales guidance was a "very difficult call". Next, returning to a normal dividend cycle, declared a 66 pence per share interim payout. It expects to declare a final dividend "no lower than" the 127p it paid in August.

----------

Holiday Inn-owner InterContinental Hotels said it is carrying out extra "recovery and assurance plans" after its technology systems were hit by "unauthorised activity" earlier this month. "Following a period of disruption, by Wednesday 7 September IHG had re-activated its booking websites and mobile app together with most of its other booking channels and revenue-generating systems. Subsequently, service at our reservation and customer care call centres has been recovered and all our systems restored," the company explained. During the disruption, its hotel sites were able to to take booking directly. "We have continued to carry out additional steps as part of our recovery and assurance plans to review and further enhance our security measures. External specialists were engaged to investigate the incident, and no evidence of unauthorised access to systems storing guest data has been identified," IHG added.

----------

M&G has named Andrea Rossi as its new chief executive, effective October 10. He succeeds John Foley who steps down after seven years in the post. Foley's retirement from the role was announced in April. The wealth manager at the time said Foley would remain in the role until a replacement was found. Rossi was formerly CEO of AXA Investment Managers and spent six years on the executive committee of parent AXA SA. "Most recently, Andrea has been a senior adviser to Boston Consulting Group. He will step down from this role following his appointment at M&G," M&G added.

----------

COMPANIES - FTSE 250

----------

Mitchells & Butlers said fourth-quarter sales topped pre-virus levels, despite the pub and bar owner facing extreme hot weather in the UK and rail strikes. In the quarter ended September 24, total sales rose 1.5% from three years earlier, before the onset of the pandemic. "Like-for-like sales improved in the fourth quarter, despite the ongoing impact of extreme heat as well as further rail strikes, both of which disrupted trade. Sales over the August bank holiday were encouraging, with like-for-like growth over the three-day weekend of over 6%, before returning to levels consistent with the quarter as a whole," the company said. For the full-year, sales were up 1.1% on pre-virus levels. Mitchells & Butlers welcome UK energy price cap measures but warned it expects its total energy and utility costs to have risen to GBP150 million for the full year, up from the pre-pandemic comparative of GBP80 million. "Even with the cap in place anticipate a further increase on that for FY 2023," it warned.

----------

Synthomer cut yearly guidance as the Essex-based chemicals maker grapples with tough market conditions. It now expects its 2022 earnings before interest, tax, depreciation and amortisation to be 10% to 15% below previous expectations. "Since August, macroeconomic conditions have deteriorated, leading to reduced demand in construction and coatings end markets. This has impacted trading in Synthomer's European business," the company warned.

----------

OTHER COMPANIES

----------

Attraqt backed a GBP63.2 million takeover offer. Technology company Crownpeak will pay 30p per share in the London-based provider of online search, merchandising and personalisation solutions for e-commerce. This represents a 70% premium to Attraqt's 17.50p closing price on Wednesday. The bid values Attraqt's equity at GBP63.2 million. Crownpeak has so far received acceptances representing 42% of Attraqt shareholders. Attraqt also reported interim results. In the first half of 2022, revenue climbed 9.4% annually to GBP12.2 million from GBP11.1 million. Its pretax loss, however, widened to GBP2.2 million from GBP1.8 million.

----------

Avon Protection said it has received a first delivery order from the US Army for a "next generation" helmet. The order is worth USD42.1 million. "Manufacturing ramp-up is progressing to plan after completing rigorous testing, with initial deliveries commencing in the first half of FY23 positioning Avon Protection as the leading helmet supplier to the US [Department of Defense]," the company said.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.